Approval · Notice of Compliance 20074 · 2017
TEVA-PROFEN: Notice of Compliance 20074
Issued November 22, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20074
- Date
- November 22, 2017
- Company
- Teva Canada LimitedToronto, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEVA-PROFEN | Not yet assigned | — |
Medicinal ingredients
- IBUPROFEN 600 MG per TAB